Loading…

MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I

The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2022-10, Vol.13, p.930590-930590
Main Authors: Mendes, Marcus Fabiano de Almeida, de Souza Bragatte, Marcelo, Vianna, Priscila, de Freitas, Martiela Vaz, Pöhner, Ina, Richter, Stefan, Wade, Rebecca C, Salzano, Francisco Mauro, Vieira, Gustavo Fioravanti
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (pMHC). However, few of these bioinformatics tools take into account the pMHC three-dimensional structure. Here, we describe a new bioinformatics tool, MatchTope, developed for predicting peptide similarity, which can trigger cross-reactivity events, by computing and analyzing the electrostatic potentials of pMHC complexes. We validated MatchTope by using previously published data from assays. We thereby demonstrate the strength of MatchTope for similarity prediction between targets derived from several pathogens as well as for indicating possible cross responses between self and tumor peptides. Our results suggest that MatchTope can enhance and speed up future studies in the fields of vaccinology and cancer immunotherapy.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.930590